Clinical Trial Update: Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of adding gemigliptin 50 mg once daily to glimepiride and metformin in patients with type 2 diabetes ina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gemigliptin (gemigliptin)

Snippet

Sponsor: LG Life Sciences | Conditions: T2DM | Phase 3 | Status: COMPLETED